Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Coldstream Capital Management Inc.

Coldstream Capital Management Inc. increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 6.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,479 shares of the medical research company’s stock after purchasing an additional 280 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Agilent Technologies were worth $660,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Marshall Financial Group LLC acquired a new position in shares of Agilent Technologies during the second quarter worth about $1,058,000. Van ECK Associates Corp grew its holdings in Agilent Technologies by 6.6% during the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock worth $442,011,000 after acquiring an additional 183,716 shares in the last quarter. AXA S.A. increased its position in shares of Agilent Technologies by 32.3% in the 2nd quarter. AXA S.A. now owns 362,945 shares of the medical research company’s stock valued at $47,049,000 after purchasing an additional 88,667 shares during the last quarter. Vestal Point Capital LP acquired a new stake in shares of Agilent Technologies in the 3rd quarter valued at $14,848,000. Finally, Empowered Funds LLC lifted its position in shares of Agilent Technologies by 29.8% during the 3rd quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company’s stock worth $4,592,000 after purchasing an additional 7,111 shares during the last quarter. Hedge funds and other institutional investors own 87.42% of the company’s stock.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $139.05 on Friday. The stock has a market capitalization of $39.95 billion, a price-to-earnings ratio of 31.46, a PEG ratio of 4.48 and a beta of 1.07. The firm’s fifty day simple moving average is $136.75 and its 200-day simple moving average is $136.52. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. Agilent Technologies, Inc. has a 12 month low of $124.16 and a 12 month high of $155.35.

Agilent Technologies (NYSE:A) last announced its earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the prior year, the company earned $1.38 earnings per share. The business’s revenue was up .8% compared to the same quarter last year. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be paid a $0.248 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a dividend yield of 0.71%. The ex-dividend date of this dividend is Tuesday, December 31st. Agilent Technologies’s dividend payout ratio (DPR) is 22.40%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on A. TD Cowen increased their target price on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Stifel Nicolaus reiterated a “buy” rating and issued a $151.00 price objective on shares of Agilent Technologies in a report on Monday, August 26th. StockNews.com cut Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday, November 26th. Citigroup increased their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Sanford C. Bernstein reduced their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of “Hold” and an average price target of $143.62.

Insider Activity

In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.33% of the company’s stock.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.